Overview
Stellate Ganglion Block as Novel Treatment for Heart Failure Patients
Description
Stellate Ganglion Block as Novel Treatment for Heart Failure Patients
Eligibility
Inclusion Criteria:
- Age 18 : 70 years old.
- NYHA Class III-IV Heart Failure.
- Heart failure with a reduced ejection fraction (HFrEF) LVEF ≤ 40% calculated using 2D echocardiography and Biplane Simpson's .
- Optimal tolerated Medical Therapy for Heart Failure.
Exclusion Criteria:
- Active Malignancy.
- Acute heart failure including pulmonary edema or cardiogenic shock.
- Severe, life-threatening non-cardiac disease.
- Pregnancy.
- Localized infection.
- Coagulopathy or anticoagulated patients.
- Refused this procedure.